""
Aducanumab: The Beginning of the End of Alzheimer’s Disease?
Jason Karlawish, MD, writes in STAT: In histories written about Alzheimer’s disease, 2019 will turn up as a landmark year, one in which researchers, clinicians, patients,...
Advancing Algorithmic Care
The keynote lecture was delivered by Penn Integrates Knowledge Professor Ezekiel Emanuel, whose main message to the audience was “We must be humble,” emphasized that AI must...